Recipient: Stuart Orkin, MD
Director/Moderator: Jose Cancelas, MD, PhD
Speaker: Stuart Orkin, MD
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching level: Intermediate to Advanced
- The global impact of hemoglobin disorders and potential strategies for more effective management and/or cure.
- The relevance of the human fetal-to-adult hemoglobin switch for the hemoglobin disorders.
- New genetic approaches, genome-wide association studies (GWAS) and gene editing, and their power for understanding human disease biology. 4. Challenges and potential solutions, in bringing new knowledge and genetic tools to innovate therapy for patients.
- Challenges and potential solutions, in bringing new knowledge and genetic tools to innovate therapy for patients.
Event Description: Event Description: Initiated in 1954 to honor Karl Landsteiner, MD, whose lifetime research laid the foundation for modern blood transfusion therapy, this award recognizes a scientist whose original research resulted in an important contribution to the body of scientific knowledge. The scientist who receives the award shall have an international reputation in transfusion medicine or cellular therapies. The title of Dr. Orkins presentation is Solving the human fetal-to-adult hemoglobin switch.
Location: OCCC - W240